ABBV vs. MYTHY

Last updated Jun 13, 2026

ABBV (AbbVie Inc.) and MYTHY (Mytilineos Holdings SA ADR) are both stocks. ABBV operates in Drug Manufacturers - General (Healthcare), while MYTHY operates in Conglomerates (Industrials).

Performance

ABBV vs. MYTHY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbbVie Inc. (ABBV) and Mytilineos Holdings SA ADR (MYTHY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ABBV

• 1D: 1.32%
• 1M: 9.22%
• YTD: 1.30%
• 6M: 3.65%
• 1Y: 22.21%
• 3Y*: 22.39%
• 5Y*: 18.94%
• 10Y*: 19.10%

MYTHY

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ABBV vs. MYTHY - Yearly Performance Comparison

	2026 (YTD)
ABBV AbbVie Inc.	4.84%
MYTHY Mytilineos Holdings SA ADR	0.00%

Fundamentals

Market Cap ABBV : $403.99B MYTHY : $8.32B
EPS ABBV : $2.05 MYTHY : €2.95
PE Ratio ABBV : 110.96 MYTHY : 17.11
PS Ratio ABBV : 6.43 MYTHY : 1.38
Total Revenue (TTM) ABBV : $62.82B MYTHY : €5.21B
Gross Profit (TTM) ABBV : $46.15B MYTHY : €667.88M
EBITDA (TTM) ABBV : $17.96B MYTHY : €692.66M

Return for Risk

ABBV vs. MYTHY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABBV

ABBV Risk / Return Rank: 68
ABBV Sharpe Ratio Rank: 72
ABBV Sortino Ratio Rank: 66
ABBV Omega Ratio Rank: 65
ABBV Calmar Ratio Rank: 68
ABBV Martin Ratio Rank: 68

MYTHY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABBV vs. MYTHY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Mytilineos Holdings SA ADR (MYTHY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ABBV	MYTHY	Difference
Sharpe ratio: Return per unit of total volatility	0.92	—	—
Sortino ratio: Return per unit of downside risk	1.42	—	—
Omega ratio: Gain probability vs. loss probability	1.18	—	—
Calmar ratio: Return relative to maximum drawdown	1.29	—	—
Martin ratio: Return relative to average drawdown	2.88	—	—

Drawdowns

ABBV vs. MYTHY - Drawdown Comparison

The maximum ABBV drawdown since its inception was -45.09%, which is greater than MYTHY's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for ABBV and MYTHY.

Drawdown Indicators

	ABBV	MYTHY	Difference
Max Drawdown Largest peak-to-trough decline	-45.09%	0.00%	-45.09%
Max Drawdown (1Y) Largest decline over 1 year	-17.32%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-20.74%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-21.92%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-45.09%	—	—
Current Drawdown Current decline from peak	-4.60%	0.00%	-4.60%
Average Drawdown Average peak-to-trough decline	-10.71%	0.00%	-10.71%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.75%	—	—

Volatility

Volatility by Period

	ABBV	MYTHY	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.10%	—	—
Volatility (6M) Calculated over the trailing 6-month period	17.85%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	24.31%	0.00%	+24.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.89%	0.00%	+22.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.73%	0.00%	+25.73%

Dividends

ABBV vs. MYTHY - Dividend Comparison

ABBV's dividend yield for the trailing twelve months is around 2.96%, while MYTHY has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABBV AbbVie Inc.	2.96%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%
MYTHY Mytilineos Holdings SA ADR	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

ABBV vs. MYTHY - Profitability Comparison

The chart below illustrates the profitability comparison between AbbVie Inc. and Mytilineos Holdings SA ADR over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

MYTHY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Mytilineos Holdings SA ADR reported a gross profit of 180.41M and revenue of 1.80B. Therefore, the gross margin over that period was 10.0%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

MYTHY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Mytilineos Holdings SA ADR reported an operating income of 142.56M and revenue of 1.80B, resulting in an operating margin of 7.9%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.

MYTHY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Mytilineos Holdings SA ADR reported a net income of 126.88M and revenue of 1.80B, resulting in a net margin of 7.0%.